Compare ARK Genomic Revolution ETF (ARKG) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Financial Select Sector SPDR Fund — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Financial Select Sector SPDR Fund trades at $55.9. Which is the better fit depends on your goals.
| ARKG | XLF | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $56.41 |
52-Week Low | $23.09 | $47.80 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XLF trades at $55.71, up 0.31% today, with a bullish technical signal from moving averages and strong trend momentum indicated by ADX readings above 55. The ETF is positioned ahead of Q2 bank earnings reports, with news highlighting potential benefits from Federal Reserve rate hikes and recent dividend increases following positive stress test results. Support rests near $55, with resistance at $56.
Outlook is cautiously optimistic as financial sector strength and higher interest rates could drive gains, though overbought RSI levels and geopolitical tensions pose near-term risks. Investor focus remains on earnings performance and macroeconomic policy shifts for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
